| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Craneware PLC
Craneware PLC
LSE:CRW
Craneware PLC
Capital Expenditures
Craneware PLC
Capital Expenditures Peer Comparison
RENX
COG
IUG
INS
EMIS
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Craneware PLC
LSE:CRW
|
Capital Expenditures
-$16.7m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-37%
|
|
|
Renalytix PLC
LSE:RENX
|
Capital Expenditures
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cambridge Cognition Holdings PLC
LSE:COG
|
Capital Expenditures
-£33k
|
CAGR 3-Years
8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-5%
|
|
|
Intelligent Ultrasound Group PLC
LSE:IUG
|
Capital Expenditures
-£2.1m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Instem PLC
LSE:INS
|
Capital Expenditures
-£3.5m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
EMIS Group PLC
LSE:EMIS
|
Capital Expenditures
-£6.5m
|
CAGR 3-Years
17%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
See Also
What is Craneware PLC's Capital Expenditures?
Capital Expenditures
-16.7m
USD
Based on the financial report for Dec 31, 2023, Craneware PLC's Capital Expenditures amounts to -16.7m USD.
What is Craneware PLC's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-37%
Over the last year, the Capital Expenditures growth was -17%. The average annual Capital Expenditures growth rates for Craneware PLC have been -18% over the past three years , -18% over the past five years , and -37% over the past ten years .
You don't have any saved screeners yet
